Petrichor Healthcare Capital Management LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Petrichor Healthcare Capital Management LP
CRD #288664
SEC #801-112209
CIK #0001913004
AUM 966.5 M (2026-03-31)
Employees 16 (75% Investors, 0% Brokers)
Fees
Minimum
Phone646-443-6606
Address220 East 42nd Street
New York, NY 10017
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($M)
100080060040020002010201520212027
Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure]
Item 5: Fees and Compensation

The Firm’s fees and compensation are fully described in the Funds’ Offering Documents.
Pursuant to the Offering Documents, Petrichor receives a management fee during the
investment period payable at the maximum rate of 2% per annum on Fund commitments, pro-
rated for partial quarters. Following the investment period, Petrichor will receive a
management fee payable at a reduced fee on the lesser of Fund commitments or the fair
market value of Fund investments, pro-rated for partial quarters. Petrichor deducts
management fees directly from the Fund’s assets, quarterly in advance. In general, the
proration of management fees is calculated based on the number of days remaining in the
applicable quarter, and it would be Petrichor’s policy to refund management fees on a prorated
basis upon the termination of Petrichor’s investment management agreement with the Funds.

Petrichor renders its services to the Funds at its own expense, including its overhead expenses
such as salaries and fringe benefits of its personnel, rent, office equipment, newspapers and
other mass-market periodicals, computer equipment, data processing, utilities of any office
space maintained, office supplies, secretarial services, and any other overhead-type expenses.

All other expenses are borne by the Funds, including operating expenses such as private
placement fees, appraisal fees, brokerage fees, expenses relating to hedging, legal and
accounting fees, taxes and other governmental charges levied against the Fund, regulatory

expenses, “broken deal” expenses, interest expenses incurred in respect of indebtedness,
reimbursement of the Funds’ pro-rata share of any reasonable expenses of the Advisory
Committee, and other fees or expenses determined by the Advisory Committee to be related
to the Fund’s affairs. The inclusion of an expense category in a Fund’s Offering Documents will
not impose on Petrichor an obligation to charge an expense (or the full amount of that
expense) to that Fund; instead, permitted expenses will be allocated and charged in Petrichor’s
discretion to the Fund(s) it deems appropriate.

Transaction fees, advisory fees, directors’ fees, investment banking fees, break-up fees, and
other similar fees received by Petrichor relating to Fund investments will first be applied to
unreimbursed expenses of Petrichor related to the applicable transaction, with 80% of the
excess of any such fees applied to offset and reduce future management fees. Organizational
expenses up to $1.25 million would have been paid by the Funds, with any excess serving to
reduce management fees. Additional information regarding fees and other expenses can be
found in each Fund’s Offering Documents.

Scion receives operating expense amounts as more fully described in the Scion Life Sciences
I, LLC governing documents. The operating expenses charged to Scion Life Sciences I, LLC are
reduced by the amount of any transaction fees, break-up fees, advisory fees, director’s fees,
monitoring fees, and other similar fees received by Scion or its affiliates.

The Funds have entered into letter agreements or other similar agreements (collectively, “Side
Letters”) with one or more investors that alter, modify or change the terms of the interests
held by such investors. Side Letters provide such investor(s) with additional and/or different
rights (including, without limitation, with respect to the carried interest, management fee,
withdrawal rights, informational rights or other rights) than the other investors.
Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure]
Item 7: Types of Clients

The Firm provides discretionary investment advice solely to its Fund clients, and references
throughout this Brochure to “clients” and to the Firm’s related duties and practices on behalf
of its clients and/or investors should be construed accordingly. The Investors participating in
the Funds are generally “qualified purchasers” (as defined under the 1940 Act). The minimum
initial investment in the Funds is generally $5 million, subject to the applicable Fund general
partner’s or manager’s, as applicable (the “General Partner”), discretion to accept lesser
amounts.
Type Form D Funds Date Sold AUM
PE POF I Co-Invest LP [2022-03-31] 37.0 M 98.4 M
Filed 2021-04-23 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1 · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
VC Scion Life Sciences I LLC [2022-03-31] 172.2 M 296.2 M
Filed 2023-03-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
PE Petrichor Opportunities Fund I Intermediate LP 2021-03-30 177.3 M
PE Petrichor Opportunities Fund I LP [2017-07-14] 153.3 M 394.5 M
Filed 2020-07-16 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1 · Remaining Indefinite · Duration More than one year · Commission $2,283,500 · Revenue Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 6 966.5
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 6 966.5
By Discretionary
Discretionary 6 966.5
Non-Discretionary 0 0.0
Total 6 966.5
By Non-United States Persons
Non-United States Persons 263.0
United States Persons 703.5
Total 6 966.5
Form D Directors Role # Filings # Firms 2011 - 2026
Aaron Kantoff Executive Officer 14 2
Tadd Wessel Executive Officer 11 2
Samuel Hall Executive Officer 2 2
EDGAR Form CIK 2011 - 2026
SC 13G [0001913004]
Form 13D/13G Filer Form 13D/13G Subject Filed
Petrichor Healthcare Capital Management LP Lumiradx Ltd [2022-02-24]
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesPrivate Equity
Comparable Firms State AUM
Balmoral Management II LP
CA 974.4 M
Chicago Atlantic Advisers LLC
IL 970.3 M
Factorial Funds Management LLC
CA 967.0 M
Revival Healthcare Capital LLC
TX 964.3 M
Bison Capital Asset Management LLC
CA 962.5 M
Partners for Growth Managers LLC
CA 962.2 M
White Deer Management LLC
TX 960.8 M
Folium Capital LP
MA 960.3 M
Clearlist Capital LLC
NY 959.8 M
SPC Management Co Inc
NJ 959.6 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com